Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform. Built on seven years of development and ...
OpenX's new API suite provides ad buyers with a more detailed view of the bidstream and, as a result, more accurate targeting ...
OpenX Technologies, Inc., one of the world's leading omnichannel supply-side platforms, today announced the launch of OpenXBuild, a software suite that gives advertisers unprecedented real-time ...
Instagram's 2 billion users, built-in shopping tools, and visual ads help businesses reach new customers, drive sales, and ...